Should you sell Insurance Australia Group Ltd?

Insurance Australia Group Ltd (ASX:IAG)'s earnings came as a huge disappointment for investors.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Shares of general insurance business Insurance Australia Group Ltd (ASX: IAG) have come under heavy selling pressure over the last week following the release of its interim earnings report.

The insurer reported a net profit of $579 million for the period, which represented a 9.8% decline on the prior year. This was the result of heightened competition for customers and a 26% increase in natural disaster claims to $421 million. As it stands, the group's peril allowance for the full year is $700 million, with a separate insurance cover for retained perils amounting to $150 million. The total damage caused by the recent tropical cyclone Marcia is yet to be announced.

Insurance Australia Group's profit was also impacted by a 41% reduction in investment income. This is concerning given the strength of global equity markets during the reporting period.

Of course, there were positives to be taken from the report, but those barely came as a surprise. Gross Written Premiums rose 17.1% to $5.6 billion, although this came largely as a result of its recent acquisition of Wesfarmers Ltd's (ASX: WES) insurance underwriting arm late in 2013.

Should you sell?

Over the last week, the stock has fallen more than 7% from a high of $6.43 to just $5.94 today. Although it was a disappointing result from the insurer, there are still reasons to suggest it can perform for investors in the long term. For instance, it is doing a reasonable job of maintaining its margins, while the synergies from its Wesfarmers acquisition should soon become more recognisable.

For now, it seems as though holding onto your shares might be the best option. While investors will need to remain patient, at least they'll get to enjoy its solid dividend yield, currently amounting to 6.6% fully franked (or 9.4% when grossed up for franking credits).

Motley Fool contributor Ryan Newman does not own shares in any of the companies mentioned. You can follow Ryan on Twitter @ASXvalueinvest.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »